Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC

BACKGROUND: Systemic therapy is recommended for advanced non-small-cell lung cancer (NSCLC). However, conventional first-line treatment has generated a plateau in response rate of 25% to 35%. Few studies have shown patients benefit from microwave ablation (MWA) in combination with radiotherapy and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Xiang, Han, Jun-Qing, Ye, Xin, Wei, Zhi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640441/
https://www.ncbi.nlm.nih.gov/pubmed/26604789
http://dx.doi.org/10.2147/OTT.S90528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640441/
https://www.ncbi.nlm.nih.gov/pubmed/26604789
http://dx.doi.org/10.2147/OTT.S90528

Ejemplares similares